Ethambutol

CHEMBL44884 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
204.3 g/mol
LogP
-0.1
Phase
4

This antibiotic disrupts the construction of the outer cell wall of tuberculosis bacteria, preventing their growth. It is used as part of combination therapy for the treatment of active tuberculosis.

الوزن الجزيئي

204,3100 g/mol

LogP

-0,10

TPSA

64,50 Ų

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC[C@@H](CO)NCCN[C@@H](CC)CO

InChI

InChI=1S/C10H24N2O2/c1-3-9(7-13)11-5-6-12-10(4-2)8-14/h9-14H,3-8H2,1-2H3/t9-,10-/m0/s1

Molecular Formula

C10H24N2O2

HBD / HBA

4 / 4

الروابط القابلة للدوران

9

الذرات الثقيلة

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

This antibiotic disrupts the construction of the outer cell wall of tuberculosis bacteria, preventing their growth. It is used as part of combination therapy for the treatment of active tuberculosis.

Yes, Ethambutol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL44884. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 14052. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.